Pentixapharm Holding AG (ETR:PTP) | Finanzwire

Basculer en Français

10035	Companies
204313	Keywords
134648	Articles
108363	Press releases

Headlines Articles Press releases Pentixapharm Holding AG

Home
Companies
Pentixapharm Holding AG

BRIEF

published on 09/26/2025 at 08:05, 5 months 20 days ago

Pentixapharm Advances PentixaTher in AML Trial

Clinical Trial Radiopharmaceuticals Acute Myeloid Leukemia PentixaTher CXCR4-targeting
PRESS RELEASE

published on 09/26/2025 at 08:00, 5 months 20 days ago

Pentixapharm Announces Advancement of PentixaTher to Fourth Dose Level in Acute Myeloid Leukemia Trial
Pentixapharm advances PentixaTher to fourth dose level in AML trial, reinforcing safety profile and potential clinical efficacy for CXCR4-targeted radiotherapeutic in high unmet need indication

Pentixapharm CXCR4 Acute Myeloid Leukemia Radiotherapeutic PentixaTher
BRIEF

published on 05/27/2025 at 09:48, 9 months 20 days ago

Pentixapharm Unveils New Clinical Development Strategy

Oncology Pentixapharm CXCR4 Trials Theranostic Strategy Hematologic Malignancies
PRESS RELEASE

published on 05/27/2025 at 09:43, 9 months 20 days ago

EQS-Adhoc: Pentixapharm Holding AG: Pentixapharm outlines new clinical development strategy
Pentixapharm outlines new clinical development strategy focusing on CXCR4 therapeutic and diagnostic oncology programs, discontinuing PTF301 trial in MZL, preparing new trials in hematologic malignancies and Bladder Cancer

Pentixapharm CXCR4 Oncology Programs Clinical Development Strategy Theranostic Precision
BRIEF

published on 04/25/2025 at 15:44, 10 months 20 days ago

Pentixapharm to Showcase Innovative Antibody GT-008 at AACR 2025

Cancer Therapy Pentixapharm GT-008 Antibody Glycan-Dependent CD24 Targeting
PRESS RELEASE

published on 04/25/2025 at 15:39, 10 months 20 days ago

Pentixapharm to Present First-in-Class Glycan-Dependent CD24 Antibody GT-008 for Solid Tumors at AACR 2025
Pentixapharm to present novel CD24 antibody GT-008 for solid tumors at AACR 2025, showcasing glycan-dependent mechanism for targeted therapy

Solid Tumors Pentixapharm AACR 2025 GT-008 CD24 Antibody
BRIEF

published on 04/24/2025 at 14:05, 10 months 21 days ago

Pentixapharm Signs Manufacturing Deal for Yttrium-90 Therapy

Clinical Trials Eckert & Ziegler Radiopharmaceuticals Pentixapharm Yttrium-90
PRESS RELEASE

published on 04/24/2025 at 14:00, 10 months 21 days ago

Pentixapharm Signs Contract Manufacturing Agreement for Yttrium-90-based PentixaTher with Eckert & Ziegler SE
Pentixapharm signs manufacturing agreement for Yttrium-90-based PentixaTher with Eckert & Ziegler SE to produce CXCR4-targeting radiotherapeutic doses for clinical trials

Clinical Trials Eckert & Ziegler SE Pentixapharm Y90-PentixaTher Radiotherapeutic
BRIEF

published on 04/15/2025 at 08:22, 11 months 1 day ago

Pentixapharm Holding AG Reports 2024 Financial Results and 2025 Outlook

Research And Development Financial Results 2024 2025 Financial Forecast Radiopharmaceutical Innovation Pentixapharm Strategy
PRESS RELEASE

published on 04/15/2025 at 08:17, 11 months 1 day ago

Pentixapharm Holding AG Releases Financial Results for 2024 and Announces Guidance for the 2025 Financial Year
Pentixapharm Holding AG releases 2024 financial results with EUR 12.8 million net loss and guides for EUR 23.5 million loss in 2025, focusing on R&D and operating expenses

Financial Results 2024 Net Loss 2025 Pentixapharm

Accesswire

Published on 03/16/2026 at 12:00, 13 minutes ago

Gamma Resources Announces Archaeological Survey Program for Proposed Mesa Arc Drilling Project in New Mexico
Published on 03/16/2026 at 12:00, 13 minutes ago

Abasca Resources Announces Appointment of John Shmyr as Vice President, Engagement and Communications and Closing of $3.0 Million Private Placement
Published on 03/16/2026 at 12:00, 13 minutes ago

Evergold Announces Upsized Non-Brokered Private Placement of up to $6,000,000
Published on 03/16/2026 at 12:00, 13 minutes ago

CoTec Notes Portfolio Company HyProMag USA and Intelligent Lifecycle Solutions Commission Inserma Rare Earth Magnet Pre-Processing System in South Carolina
Published on 03/16/2026 at 12:00, 13 minutes ago

Rocky Shore Continues to Strengthen Its Gold Anchor Project by Adding Additional Mining Claims

View all ACCESSWIRE

EQS Group

Published on 03/16/2026 at 11:30, 42 minutes ago

Tourism Authority of Thailand premieres 'Healing Journey Thailand' global campaign in London, advancing healing led tourism vision.
Published on 03/16/2026 at 11:00, 1 hour 13 minutes ago

BIO-Europe Spring® 2026: Partnering Momentum Builds as Global Biopharma Leaders Set Course for Lisbon
Published on 03/16/2026 at 11:00, 1 hour 13 minutes ago

CTS EVENTIM: EVENTIM LIVE expands in the French live market with promoter Pierre-Alexandre Vertadier
Published on 03/16/2026 at 11:00, 1 hour 13 minutes ago

Vossloh to deliver high-speed grinding train to China
Published on 03/16/2026 at 11:00, 1 hour 13 minutes ago

Nebius signs new AI infrastructure agreement with Meta

Les Echos

Published on 03/16/2026 at 08:30, 3 hours 43 minutes ago

CDA - Update on CDA' parks solarization program
Published on 03/13/2026 at 19:50, 2 days 16 hours ago

Availability of ENGIE’S 2025 Universal Registration Document
Published on 03/13/2026 at 18:05, 2 days 18 hours ago

Availability of the 2025 Universal Registration Document of OPmobility SE
Published on 03/13/2026 at 07:30, 3 days 4 hours ago

BIOPHYTIS PRESENTS ITS DEVELOPMENT PROGRAMS IN OBESITY AND SARCOPENIA AT THE ICFSR CONFERENCE
Published on 03/12/2026 at 18:00, 3 days 18 hours ago

NEW OR RENEWED AGREEMENTS BETWEEN EURAZEO AND CERTAIN FAMILY SHAREHOLDERS

View all LES ECHOS COMFI WIRE